FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA granted supplemental approval for Lupin Pharmaceuticals’ ramipril generic under the ANDA, authorizing continued marketing of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction
• Stroke

Drugs mentioned

• Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)